Final Venture

Michael Ridpath

ISBN 10: 0140271783 / ISBN 13: 9780140271782

Published by Penguin Books Ltd, United Kingdom, London, 2001

About this Item

Simon Ayot, rising star at Revere Partners, is devastated when Frank Cook, senior partner at Revere and his father-in-law, kills the funding on his first major deal. But his anger turns to terror when a few days later Frank is found dead at his remote beach house. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.

Seller Inventory # GOR002853231

Bibliographic Details

• Title: Final Venture
• Publisher: Penguin Books Ltd, United Kingdom, London
• Publication Date: 2001
• Language: English
• ISBN 10: 0140271783
• ISBN 13: 9780140271782
• Binding: Paperback
• Condition: Very Good
• Weight: 204 grams

About this title

Synopsis

Simon Ayot, rising star at Revere Partners, is devastated when Frank Cook, senior partner at Revere and his father-in-law, kills the funding on his first major deal. But his anger turns to terror when a few days later Frank is found dead at his remote beach house.

Review

Michael Ridpath knows how to follow the money, something he did quite successfully in his previous financial thriller, The Market Maker. In Final Venture, his protagonist is Simon Ayot, a likable young British associate at Revere, a venture capital company whose senior managing partner, Frank Cook, is also Simon's father-in-law. Simon has just pulled off a major coup for the firm, so when Frank abruptly denies a life-or-death round of further investment in NetCo, Simon's most promising high-tech client, he's completely surprised. Could it be that Frank believes the rumors floating around that Simon's been having more than business meetings with a woman in the firm? Vowing to dispel the rumors and change Frank's mind about dumping NetCo, Simon goes to the Marshes, Frank's country house, only to find him murdered. The police don't believe Simon's alibi, and soon even Lisa, his wife, is suspicious.

Meanwhile, the firm is still reeling from Frank's death. Its biggest investment in BioOne, a biomedical research firm, is in trouble, and Simon's attempts to get to the bottom of it reveal a corrupt link between Revere, BioOne, and the pharmaceutical company where Lisa is employed, which suddenly becomes a takeover target. Ridpath does a good job of explaining the arcane details of venture capital financing, but makes little of his setting (Boston) and even less of character motivation. In the absence of enough evidence to arrest Simon, it's difficult to believe that Lisa would suddenly turn on her brand-new husband, and her lack of insight concerning her own father's private life seems strange in light of their supposed closeness. The writing is sometimes clumsy, but readers interested in the intricacies of high finance in the venture capital market will find this a good primer on the subject. --Jane Adams